Patent Assignment
Reel/Frame 048918/0544
Security Interest
Recorded: 2019-04-16
Pages: 4
Assignor
ESPERO BIOPHARMA, INC.
Executed: 2019-04-01
Assignee
HORIZON TECHNOLOGY FINANCE CORPORATION
312 FARMINGTON AVENUE, ATTN: LEGAL DEPARTMENT, FARMINGTON, CONNECTICUT, 06032
Covered Properties
(21)
Extended Release Aspirin
PCT:
PCT/US2017/027883 ↗
Extended Release Aspirin
PCT:
PCT/US2017/027886 ↗
Higher Dose Extended Release Aspirin
PCT:
PCT/US2017/027887 ↗
Novel enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
Patent:
6,372,783 →
Application:
09/680,873 →
Novel enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
Patent:
6,362,223 →
Application:
09/684,046 →
Novel Enantiomeric Compounds for Treatment of Cardiac Arrhythmias and Methods of Use
Novel Enantiomeric Compounds for Treatment of Cardiac Arrhythmias and Methods of Use
Novel Compounds for Treatment of Cardiac Arrhythmia, Synthesis, and Methods of Use
Materials and Methods for Treating Coagulation Disorders
Novel Compounds for Treatment of Cardiac Arrhythmia, Synthesis, and Methods of Use
Materials and Methods for Treating Coagulation Disorders
Novel Compounds for Treatment of Cardiac Arrhythmia and Methods of Use
Novel Compounds for Treatment of Cardiac Arrhythmia and Methods of Use
Antiarrhythmic Precursor Compounds, Methods of Synthesis and Methods of Use
Materials and Methods for Treating Coagulation Disorders
Haloalkyl Ester Derivatives of Coumarin for the Treatment of Coagulation Disorders
Halogenated Ester Derivatives of Coumarins for the Treatment of Coagulation Disorders
Methods for Treating Atrial Fibrillation
Extended Release Aspirin
Application:
15/131,446 →
Publication:
US 2017/0112857
Extended Release Aspirin
Application:
15/131,478 →
Publication:
US 2017/0112858
Higher Dose Extended Release Aspirin
Application:
62/323,904 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 025006 Frame 0740. Assignor(S) Hereby Confirms the Name of the Assignee Should Have Been Aryx Therapeutics. the Assignee Name Should Not Have Had Inc.
May 31, 2012
From: DRUZGALA, PASCAL; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028307/0394 →
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 022529 Frame 0584. Assignor(S) Hereby Confirms the Name of the Assignee to Be Aryx Therapeutics and Not Aryx Therapeutics, Inc..
Jun 6, 2012
From: DRUZGALA, PASCAL; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028332/0196 →
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 023164 Frame 0155. Assignor(S) Hereby Confirms the Name of the Assignee Should Be Aryx Therapeutics and Not Aryx Therapeutics, Inc..
Jun 6, 2012
From: DRUZGALA, PASCAL; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028332/0203 →
Assignment of Assignor's Interest
Jun 8, 2012
From: ARYX THERAPEUTICS
To: ARYX THERAPEUTICS, INC.
Reel/Frame 028347/0389 →
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 023164 Frame 0203. Assignor(S) Hereby Confirms the Name of the Assignee Should Be Aryx Therapeutics and Not Aryx Therapeutics Inc.
Jun 8, 2012
From: DRUZGALA, PASCAL; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028349/0801 →
Assignment of Assignor's Interest
Jun 20, 2012
From: DRUZGALA, PASCAL; ZHANG, XIAOMING; PFISTER, JURG
To: ARYX THERAPEUTICS
Reel/Frame 028411/0068 →
Assignment of Assignor's Interest
Oct 1, 2012
From: ARYX THERAPEUTICS, INC.
To: ARMETHEON, INC.
Reel/Frame 029057/0220 →
Assignment of Assignor's Interest
Oct 10, 2012
From: ARYX THERAPEUTICS, INC.
To: ARMETHEON, INC.
Reel/Frame 029105/0808 →
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 016571 Frame 0719. Assignor(S) Hereby Confirms the Name of the Assignee Should Have Been Aryx Therapeutics Without the Inc.
Oct 16, 2012
From: DRUZGALA, PASCAL
To: ARYX THERAPEUTICS
Reel/Frame 029136/0086 →
Change of Name
Oct 17, 2012
From: ARYX THERAPEUTICS
To: ARYX THERAPEUTICS, INC.
Reel/Frame 029148/0007 →
Assignment of Assignor's Interest
Oct 22, 2012
From: ARYX THERAPEUTICS, INC.
To: ARMETHEON, INC.
Reel/Frame 029169/0137 →
Correction of Assignors, Peter G. Milner Was Accidently Omitted, When Assignment Previously Recorded at Reel/Frame 029105/0808
Oct 26, 2012
From: DRUZGALA, PASCAL; MILNER, PETER G.
To: ARYX THERAPEUTICS
Reel/Frame 029201/0099 →
Release of Security Interest
Feb 6, 2013
From: AYER CAPITAL PARTNERS MASTER FUND, L.P.; MPM BIOVENTURES III, L.P.; MPM BIOVENTURES III-QP, L.P.; MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG
To: ARYX THERAPEUTICS, INC.
Reel/Frame 029767/0524 →
Assignment of Assignor's Interest
Apr 22, 2016
From: PATRICK, JEFF; DILLAHA, LARRY
To: NEW HAVEN PHARMACEUTICALS, INC.
Reel/Frame 038354/0589 →
Security Interest
Jul 8, 2016
From: NEW HAVEN PHARMACEUTICALS, INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 039106/0276 →
Assignment of Assignor's Interest
Feb 7, 2017
From: NEW HAVEN PHARMACEUTICALS, INC.
To: NEW HAVEN (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
Reel/Frame 041197/0106 →
Assignment of Assignor's Interest
Feb 7, 2017
From: NEW HAVEN (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
To: ESPERO PHARMACEUTICALS, INC.
Reel/Frame 041197/0317 →
Assignment of Assignor's Interest
Apr 20, 2017
From: DILLAHA, LARRY
To: NEW HAVEN PHARMACEUTICALS INC
Reel/Frame 042073/0220 →
Assignment of Assignor's Interest
Apr 20, 2017
From: NEW HAVEN LLC
To: ESPERO PHARMACEUTICALS INC
Reel/Frame 042073/0325 →
Assignment of Assignor's Interest
Apr 20, 2017
From: NEW HAVEN PHARMACEUTICALS INC
To: NEW HAVEN LLC
Reel/Frame 042073/0273 →
Change of Name
Jul 23, 2020
From: ARMETHEON, INC.
To: ESPERO BIOPHARMA, INC.
Reel/Frame 053293/0930 →
Assignment of Assignor's Interest
Oct 23, 2020
From: ESPERO BIOPHARMA, INC.
To: HESP LLC
Reel/Frame 054150/0011 →
Assignment of Assignor's Interest
Oct 23, 2020
From: ESPERO PHARMACEUTICALS, INC.
To: HESP LLC
Reel/Frame 054149/0959 →
Assignment of Assignor's Interest
May 4, 2022
From: HESP LLC
To: CADRENAL THERAPEUTICS
Reel/Frame 059811/0221 →
Release of Security Interest
Oct 4, 2022
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: ESPERO BIOPHARMA, INC.
Reel/Frame 061299/0927 →